A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …
Chandler Chicco has appointed Alison Wright to a newly created post to help increase the agency’s European and global services …
Major pharmaceutical companies are beginning to feel the direct effects of the austerity measures being introduced across Europe’s healthcare systems.Second …
GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …
A new survey commissioned by Pfizer shows that Europeans are fuelling a counterfeit medicines market worth €10.5 billion.The findings are …

Ever since the FDA announced its social media and internet hearing last September the big question over here has been …

The European Commission has launched a new series of raids on pharmaceutical companies as part of its crackdown on alleged …

A new report on the state of biotech and pharmaceutical R&D in Europe says the sector is suffering from a …

Responsibility for pharma and biotech policy has been taken away from the European Commission’s Enterprise and Industry directorate and handed to the …
The September issue of Pharmafocus marks a new stage in the publication’s development with an expanded monthly circulation that takes …
Europe’s member states are at loggerheads over plans to relax current restrictions on pharma communicating with patients.The plans tabled by …
Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …
Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …